Related Experiment Video
Updated: Aug 20, 2026

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
Virokines in the pathogenesis of cancer: focus on human herpesvirus 8
Mariam Klouche1, Giuseppe Carruba, Luigi Castagnetta
1Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany. mariam.klouche@laborzentrum-bremen.de
Abstract:
During evolution, DNA viruses have captured a broad array of cellular genes involved in immune recognition and growth control that are nonessential for viral replication. The encoded virokines and viroceptors may act as mimetics or antagonists of their cellular homologues, altering signal transduction and cell communication towards survival of virus-infected cells. Human herpesvirus type 8 (HHV8) is the most recently identified human oncogenic herpesvirus. It is associated with Kaposi's sarcoma and lymphoproliferative diseases, such as pleural effusion lymphomas and multicentric Castleman's disease. HHV8 has captured a unique number of cellular regulatory genes, which redirect gene expression and cell growth, prevent apoptosis and immune recognition, and interfere with tumor suppressor gene function. HHV8 encodes a unique virokine, viral interleukin-6, which is particularly relevant for the pathogenesis of HHV8-associated tumors, since it participates in transformation and mediates autocrine and paracrine mitogenic and proinflammatory effects. Viral IL-6 differs fundamentally from human IL-6 in receptor engagement for signal transduction and thus constitutes a singular model to understand the facets of human and viral cytokine biology. We provide an overview of the role of virokines in cancer, with a particular focus on the differences of human and viral IL-6 in the pathophysiology of HHV8-associated tumors.
Insights
Human herpesvirus 8 (HHV8) hijacks cellular genes, creating viral versions like viral interleukin-6. This unique protein drives HHV8-associated tumor growth by altering cell signaling and immune responses.
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- DNA viruses capture cellular genes for immune evasion and growth control.
- Human herpesvirus 8 (HHV8) is an oncogenic virus linked to Kaposi's sarcoma and lymphomas.
- HHV8 encodes viral proteins that manipulate host cell functions.
Purpose of the Study:
- To review the role of viral cytokines (virokines) in cancer.
- To highlight the unique viral interleukin-6 (vIL-6) encoded by HHV8.
- To compare vIL-6 with human IL-6 in HHV8-associated tumor pathophysiology.
Main Methods:
- Literature review on virokines and HHV8 pathogenesis.
- Comparative analysis of viral and human interleukin-6 signaling.
- Discussion of HHV8's manipulation of cellular regulatory genes.
Main Results:
- HHV8 captures cellular genes, including those for immune recognition and growth control.
- HHV8 encodes a unique vIL-6, essential for tumor transformation and proliferation.
- vIL-6 differs from human IL-6 in receptor binding and signal transduction.
Conclusions:
- Viral mimicry of cellular genes is a key viral strategy.
- vIL-6 plays a critical role in HHV8-driven oncogenesis.
- Understanding vIL-6 provides insights into cytokine biology and viral pathogenesis.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Cytomegalovirus Disease
Cancers Originate from Somatic Mutations in a Single Cell

